The global home infusion therapy market is estimated to be worth USD 35.1 billion in 2022 and to reach USD 51.81 billion in 2027, growing at a CAGR of 8.1%
Growing prevalence of chronic diseases
Growing Geriatric Population and the Presence of Health Facilities
Growing demand for intravenous drug infusion therapy for home care
Lack of reimbursement for home infusion therapy
Continuous improvements and technological advances in home infusion therapy
Acceleration of Investments in Research and Development Activities
Limited Availability of Qualified Professionals
The global home infusion therapy market is segmented on the basis of product, indication and geography.
By products, the market is classified into Infusion Pumps, IV Sets, IV Cannulas, and Needleless Connectors.
By Indication, the market is classified into Anti-Infectives, Chemotherapy, Enteral Nutrition, Therapeutic Hydration, Immunoglobulin Therapy, Total Parenteral Nutrition and Others.
By geography, the market is classified into the Americas, Europe, Middle East and Africa, and Asia Pacific.
The report provides a detailed analysis of competitors in the market. Covers financial performance analysis for publicly traded companies in the market. The report also offers detailed information about the recent development and competitive landscape of the companies. Some of the companies covered in this report are B. Braun Melsungen Ag, Baxter International Inc., Becton, Dickinson and Company, Coram LLC, CVS Health Corp., Eli Lilly and Company, Fresenius Kabi AB, ICU Medical Inc., Interim HealthCare Inc. , etc
America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of the Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, UAE, Rest of MEA)
Asia Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia Pacific)
The report includes the Competitive Quadrant, a proprietary tool for analyzing and evaluating the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors to categorize players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, market share growth, etc.
The report features an in-depth analysis of the Ansoff matrix for the global home infusion therapy market. The Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to outline strategies for the company’s growth. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved in each approach.
The analyst analyzes the global home infusion therapy market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, the analyst has come up with suitable strategies for market growth.
Main topics covered:
1 Report description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Home Infusion Therapy Market by Product
7 Global Home Infusion Therapy Market by Indication
8 Americas Home Infusion Therapy Market
9 Europe Home Infusion Therapy Market
10 Home Infusion Therapy Market in the Middle East and Africa
11 APAC Home Infusion Therapy Market
12 Competitive Scenario
13 company profiles
B. Braun Melsungen Ag
Baxter International, Inc.
Becton, Dickinson and Company
CVS Health Corp.
Eli Lilly and Company
Fresenius Kabi AB
ICU Medical, Inc.
Interim HealthCare, Inc.
JMS Co., Ltd.
KKR & Co. Inc.
Option Care, Inc.
Smiths Medical, PLC
Soleo Health Holdings, Inc.
For more information on this report, please visit https://www.researchandmarkets.com/r/qgu2k6